Table 1.
Participant characteristics (N = 255)
| Age, y | 56 (±12) |
| BMI, kg/m2 | 29 (±6) |
| Diabetes mellitus (%) | 31 (12) |
| Tobacco use (%) | 47 (18) |
| POP-Q stage | 2 (2–3) |
| Preoperative PVR, mL | 74.23 (±108) |
| Postoperative void trial, mL | |
| Postoperative PVR | 136 (±177) |
| Voided volume | 221 (±203) |
| Total surgical time, min | 152 (±97) |
| Estimated blood loss, mL | 85 (±122) |
| Surgical procedures (%) | |
| Midurethral sling | 144 (54) |
| Hysterectomy | 90 (34) |
| Anterior repair | 75 (28) |
| Posterior repair | 72 (27) |
| Vault suspension | 119 (45) |
| Obliterative prolapse repair | 10 (4) |
| Anesthesia administered (%) | |
| General | 231 (88) |
| MAC | 24 (9) |
| Neuraxial | 11 (4) |
Data reported as means ± standard deviations, n (%) or median (interquartile range 25th–75th percentile). BMI, body mass index; MAC, monitored anesthesia care; POP-Q, pelvic organ prolapse quantification; PVR, postvoid residual volume.